Enrique Chacon-Cruz: Thrombocytopenia and ITP Risk After Vaccination
Enrique Chacon-Cruz, Member, Health Equity Committee at European Society of Medicine, Chief Editor of Vaccines Beat, shared a post on LinkedIn about a recent article by Matthew Z. Dudley et al., published in Vaccine, adding:
“Incidence, risk factors, and association with vaccination of thrombocytopenia and immune thrombocytopenia (ITP): A scoping review.
Dudley MZ, Ali H, Villaescusa MR, Law B.
Thrombocytopenia is a rare event with multiple potential causes, making careful assessment essential when evaluating vaccine safety signals.
This updated Brighton Collaboration review found background incidence estimates ranging widely from 1.6 to 92.1 cases per 100,000 person-years and identified numerous non-vaccine risk factors.
Evidence consistently supports an increased risk of immune thrombocytopenia (ITP) following measles-containing vaccines, while several studies also identified increased risk after adenoviral COVID-19 vaccines.
In contrast, most studies found no association with other vaccines, including mRNA and inactivated COVID-19 vaccines.
These findings reinforce the importance of standardized case definitions and consideration of background risk when assessing adverse events following immunization.”
Title: Incidence, risk factors, and association with vaccination of thrombocytopenia and immune thrombocytopenia (ITP): A scoping review
Authors: Matthew Z. Dudley, Hammad Ali, Marta Rojo Villaescusa, Barbara Law
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 16, 2026, 05:25Paul Armstrong: Honoured to Take the Lead at The Platelet Society
-
Sep 16, 2026, 05:05Alejandro González Veliz: Why Heart Attacks in Women Can Be More Complex Than a Simple Blockage
-
Sep 16, 2026, 04:58Thomas Dayspring – Your LDL Is Normal – But Are You Really Safe?
-
Sep 16, 2026, 04:50Seema Dawood: Why Some Red Cells Break While Others Survive?
-
Sep 16, 2026, 04:42GNE-Related Thrombocytopenia – Novel Findings – JTH
-
Sep 16, 2026, 04:40Managing Acute Emergencies in Thalassaemia and Sickle Cell Disease – TIF
-
Sep 16, 2026, 03:21Linda Shore-Lesserson: Dr. Nadia Hensley Delivers Visiting Lecture on Platelet Function Testing
-
Sep 15, 2026, 23:35Katya McCarthy: From Lab Specialist to Patient – Facing Polycythemia and Venous Thrombosis
-
Sep 15, 2026, 23:19Narat Srivali: Chronic Preoperative Corticosteroid Use Associated with 51% Higher Postoperative VTE Risk